Etomidate Shows Prospect as an Anti-Arrhythmic Drug Conferring Safe Sedation and Sinus Conversion Simultaneously

This case is of a 76-year-old man with a known history of hypertension, type 2 diabetes mellitus, and ischemic heart disease, who presented to our department with chest pain and palpitations. His electrocardiogram showed a ventricular tachycardia (VT), but fortunately our patient was hemodynamically...

Full description

Bibliographic Details
Main Authors: Maryam Saif Al Ali, Anas Musa, Wael Hamadeh, Esam Seddik
Format: Article
Language:English
Published: Knowledge E 2020-10-01
Series:Dubai Medical Journal
Subjects:
Online Access:https://www.karger.com/Article/FullText/510598
_version_ 1826908432885612544
author Maryam Saif Al Ali
Anas Musa
Wael Hamadeh
Esam Seddik
author_facet Maryam Saif Al Ali
Anas Musa
Wael Hamadeh
Esam Seddik
author_sort Maryam Saif Al Ali
collection DOAJ
description This case is of a 76-year-old man with a known history of hypertension, type 2 diabetes mellitus, and ischemic heart disease, who presented to our department with chest pain and palpitations. His electrocardiogram showed a ventricular tachycardia (VT), but fortunately our patient was hemodynamically stable. A trial of adenosine was given to convert the patient’s heart back to sinus rhythm, but was unsuccessful and the rhythm remained as VT. Soon after, the patient suddenly became hemodynamically unstable as his blood pressure acutely declined; thus, the decision to perform a direct current cardioversion was taken. Bearing in mind that the patient was still awake, he was given 10 mg of intravenous etomidate as a pre-procedural sedative. During the time it took to prepare for the procedure, the patient’s rhythm reverted from VT to a regular sinus rhythm, raising his blood pressure back to normal and achieving hemodynamic stablility, negating the need of any electrical or chemical cardioversion. Our patient was then handed over to the cardiology team for an emergency percutaneous coronary intervention procedure and an implantable cardioverter-defibrillator procedure, both of which were successful. Etomidate was used in this case for the purpose of sedation, and as luck would have it, it seems that it had also incidentally reverted the arrhythmia back to normal.
first_indexed 2024-12-21T22:50:54Z
format Article
id doaj.art-7b01c8d0b93c40ca9213ac1b19f177b2
institution Directory Open Access Journal
issn 2571-726X
language English
last_indexed 2025-02-17T09:22:50Z
publishDate 2020-10-01
publisher Knowledge E
record_format Article
series Dubai Medical Journal
spelling doaj.art-7b01c8d0b93c40ca9213ac1b19f177b22025-01-02T12:05:14ZengKnowledge EDubai Medical Journal2571-726X2020-10-011410.1159/000510598510598Etomidate Shows Prospect as an Anti-Arrhythmic Drug Conferring Safe Sedation and Sinus Conversion SimultaneouslyMaryam Saif Al AliAnas MusaWael HamadehEsam SeddikThis case is of a 76-year-old man with a known history of hypertension, type 2 diabetes mellitus, and ischemic heart disease, who presented to our department with chest pain and palpitations. His electrocardiogram showed a ventricular tachycardia (VT), but fortunately our patient was hemodynamically stable. A trial of adenosine was given to convert the patient’s heart back to sinus rhythm, but was unsuccessful and the rhythm remained as VT. Soon after, the patient suddenly became hemodynamically unstable as his blood pressure acutely declined; thus, the decision to perform a direct current cardioversion was taken. Bearing in mind that the patient was still awake, he was given 10 mg of intravenous etomidate as a pre-procedural sedative. During the time it took to prepare for the procedure, the patient’s rhythm reverted from VT to a regular sinus rhythm, raising his blood pressure back to normal and achieving hemodynamic stablility, negating the need of any electrical or chemical cardioversion. Our patient was then handed over to the cardiology team for an emergency percutaneous coronary intervention procedure and an implantable cardioverter-defibrillator procedure, both of which were successful. Etomidate was used in this case for the purpose of sedation, and as luck would have it, it seems that it had also incidentally reverted the arrhythmia back to normal.https://www.karger.com/Article/FullText/510598etomidateanti-arrhythmic drugventricular tachycardiasupraventricular tachycardia
spellingShingle Maryam Saif Al Ali
Anas Musa
Wael Hamadeh
Esam Seddik
Etomidate Shows Prospect as an Anti-Arrhythmic Drug Conferring Safe Sedation and Sinus Conversion Simultaneously
Dubai Medical Journal
etomidate
anti-arrhythmic drug
ventricular tachycardia
supraventricular tachycardia
title Etomidate Shows Prospect as an Anti-Arrhythmic Drug Conferring Safe Sedation and Sinus Conversion Simultaneously
title_full Etomidate Shows Prospect as an Anti-Arrhythmic Drug Conferring Safe Sedation and Sinus Conversion Simultaneously
title_fullStr Etomidate Shows Prospect as an Anti-Arrhythmic Drug Conferring Safe Sedation and Sinus Conversion Simultaneously
title_full_unstemmed Etomidate Shows Prospect as an Anti-Arrhythmic Drug Conferring Safe Sedation and Sinus Conversion Simultaneously
title_short Etomidate Shows Prospect as an Anti-Arrhythmic Drug Conferring Safe Sedation and Sinus Conversion Simultaneously
title_sort etomidate shows prospect as an anti arrhythmic drug conferring safe sedation and sinus conversion simultaneously
topic etomidate
anti-arrhythmic drug
ventricular tachycardia
supraventricular tachycardia
url https://www.karger.com/Article/FullText/510598
work_keys_str_mv AT maryamsaifalali etomidateshowsprospectasanantiarrhythmicdrugconferringsafesedationandsinusconversionsimultaneously
AT anasmusa etomidateshowsprospectasanantiarrhythmicdrugconferringsafesedationandsinusconversionsimultaneously
AT waelhamadeh etomidateshowsprospectasanantiarrhythmicdrugconferringsafesedationandsinusconversionsimultaneously
AT esamseddik etomidateshowsprospectasanantiarrhythmicdrugconferringsafesedationandsinusconversionsimultaneously